Table 2.
Patient and tumour characteristics of 309 cases of early breast cancer
| Clinico-pathological feature | Distribution (percentage of cases with data) |
|---|---|
| Age, years | |
| Median | 58 |
| Range | 28−85 |
| <50 | 92 (29.9 %) |
| >50 | 216 (70.1 %) |
| Tumour size | |
| <2 cm | 114 (41.3 %) |
| 2−5 cm | 153 (55.4 %) |
| >5 cm | 9 (3.3 %) |
| Not known | 33 |
| LN status | |
| Positive | 132 (46.2 %) |
| Negative | 154 (53.8 %) |
| Not known | 23 |
| Histological Grade | |
| 1 | 56 (20.1 %) |
| 2 | 121 (43.4 %) |
| 3 | 102 (36.6 %) |
| Not known | 30 |
| ER (Estrogen Receptor) status | |
| Positive | 226 (75.6 %) |
| Negative | 73 (24.4 %) |
| Not known | 10 |
| HER2 status (IHC 3+ or FISH + ve) | |
| Positive | 26 (16.8 %) |
| Negative | 129 (83.2 %) |
| Not known | 154 |
| Recurrence (Local, regional, distant or death when death was known to be caused by breast cancer) | |
| Total | 111/309 (35.9 %) |
| Median time to recurrence (years) | 3.14 |
| Range (years) | 0.05−19.05 |
| Mortality | |
| Total deaths with known cause | 148 |
| Deaths due to breast cancer | 83 (56 %) |
| Deaths with breast cancer present at death | 57 (38.5 %) |
| Deaths due to causes other than breast cancer | 8 (5.4 %) |
| Not known | 12 |
| Overall survival (years) | |
| Median | 13.48 |
| Range | 0.33−18.11 |
| Follow-up (years) | |
| Median | 13 |
| Range | 1−17.2 |